UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression

Journal of hepatology, 2024-11, Vol.81 (5), p.794-805

2024

Volltextzugriff (PDF)

Impact of alternative splicing on cholangiocarcinoma progression through metabolic rewiring-induced epigenetic events

Journal of hepatology, 2024-10, Vol.81 (4), p.587-589

2024

Volltextzugriff (PDF)

Mycophenolate mofetil in autoimmune hepatitis: Are we ready for primetime?

Journal of hepatology, 2024-10, Vol.81 (4), p.e183-e184

2024

Volltextzugriff (PDF)

From the Editor's Desk

Journal of hepatology, 2024-10, Vol.81 (4), p.581

2024

Volltextzugriff (PDF)

Genomic testing for inborn errors of immunity in seronegative autoimmune hepatitis of childhood

Journal of hepatology, 2024-10, Vol.81 (4), p.e151-e152

2024

Volltextzugriff (PDF)

Cirrhosis decompensation: Clinical and prognostic analysis from a new perspective

Journal of hepatology, 2024-10, Vol.81 (4), p.e168-e169

2024

Volltextzugriff (PDF)

Osteoporosis in patients with hepatitis B receiving tenofovir disoproxil fumarate: Does fibroblast growth factor 23 play a role?

Journal of hepatology, 2024-10, Vol.81 (4), p.e196-e197

2024

Volltextzugriff (PDF)

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

Journal of hepatology, 2024-10, Vol.81 (4), p.630-640

2024

Volltextzugriff (PDF)

The transition from NAFLD to MASLD and its impact on clinical practice and outcomes

Journal of hepatology, 2024-10, Vol.81 (4), p.e155-e156

2024

Volltextzugriff (PDF)

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial

Journal of hepatology, 2024-10, Vol.81 (4), p.621-629

2024

Volltextzugriff (PDF)

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

Journal of hepatology, 2024-10, Vol.81 (4), p.641-650

2024

Volltextzugriff (PDF)

Reply to: “Evidence and choice: The BCLC vision for tailoring clinical decision-making”

Journal of hepatology, 2024-10, Vol.81 (4), p.e178-e180

2024

Volltextzugriff (PDF)

Does long-term use of tenofovir disoproxil fumarate affect fracture risk in patients with chronic hepatitis B?

Journal of hepatology, 2024-10, Vol.81 (4), p.e199-e200

2024

Volltextzugriff (PDF)

Reply to: “Mycophenolate mofetil in autoimmune hepatitis: Are we ready for primetime?”

Journal of hepatology, 2024-10, Vol.81 (4), p.e185-e186

2024

Volltextzugriff (PDF)

Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD

Journal of hepatology, 2024-10, Vol.81 (4), p.600-608

2024

Volltextzugriff (PDF)

Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort

Journal of hepatology, 2024-10, Vol.81 (4), p.e162-e164

2024

Volltextzugriff (PDF)

Estrogen receptor alpha in the female liver: Dr. Jekyll and Mr. Hyde

Journal of hepatology, 2024-10, Vol.81 (4), p.763-765

2024

Volltextzugriff (PDF)

Integration of new technologies in the multidisciplinary approach to primary liver tumours: The next-generation tumour board

Journal of hepatology, 2024-10, Vol.81 (4), p.756-762

2024

Volltextzugriff (PDF)

Reply to: correspondance on “A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis”

Journal of hepatology, 2024-10, Vol.81 (4), p.e170-e171

2024

Volltextzugriff (PDF)

Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation

Journal of hepatology, 2024-10, Vol.81 (4), p.743-755

2024

Volltextzugriff (PDF)

Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms

Journal of hepatology, 2024-10, Vol.81 (4), p.590-599

2024

Volltextzugriff (PDF)

Evidence and choice: The BCLC vision for tailoring clinical decision-making

Journal of hepatology, 2024-10, Vol.81 (4), p.e176-e177

2024

Volltextzugriff (PDF)

Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both

Journal of hepatology, 2024-10, Vol.81 (4), p.e157-e159

2024

Volltextzugriff (PDF)

Endoscopic diagnosis and treatment for portal hypertension: not yet ready for clinical practice

Journal of hepatology, 2024-10, Vol.81 (4), p.e181-e182

2024

Volltextzugriff (PDF)

Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD

Journal of hepatology, 2024-10, Vol.81 (4), p.651-666

2024

Volltextzugriff (PDF)

1 – 25 von 28.581

Suche als RSS-Feed

Aktive Filter

SpracheNiederländisch

Zeitschrift / SerieJournal Of Hepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28.581)
Mit Volltextzugriff
(28.581)

Publikationsform

Artikel
(28.581)

Sprache

Englisch
(28.566)
Spanisch
(15)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(20.132)
Gastroenterology & Hepatology
(12.179)
Life Sciences & Biomedicine
(12.175)
Science & Technology
(12.175)
Humans
(8.949)
Biological And Medical Sciences
(5.661)
Medical Sciences
(5.388)
Male
(5.306)
Female
(4.338)
Gastroenterology. Liver. Pancreas. Abdomen
(3.472)
Middle Aged
(3.346)
Adult
(2.977)
Animals
(2.713)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(2.424)
Other Diseases. Semiology
(1.897)
Aged
(1.887)
Infectious Diseases
(1.233)
Liver - Pathology
(1.217)
Viral Diseases
(1.146)
Viral Hepatitis
(1.133)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(28.581)
IngentaConnect
(28.581)
Elsevier ScienceDirect Journals Complete
(28.581)
Journals@Ovid Complete
(28.574)
MEDLINE
(10.623)
IngentaConnect Journals
(285)
EZB Electronic Journals Library
(1)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

4 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

CRISPR-Cas13b-mediated suppression of HBV replication and protein expression

Impact of alternative splicing on cholangiocarcinoma progression through metabolic rewiring-induced epigenetic events

Mycophenolate mofetil in autoimmune hepatitis: Are we ready for primetime?

From the Editor's Desk

Genomic testing for inborn errors of immunity in seronegative autoimmune hepatitis of childhood

Cirrhosis decompensation: Clinical and prognostic analysis from a new perspective

Osteoporosis in patients with hepatitis B receiving tenofovir disoproxil fumarate: Does fibroblast growth factor 23 play a role?

Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network

The transition from NAFLD to MASLD and its impact on clinical practice and outcomes

Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis

Reply to: “Evidence and choice: The BCLC vision for tailoring clinical decision-making”

Does long-term use of tenofovir disoproxil fumarate affect fracture risk in patients with chronic hepatitis B?

Reply to: “Mycophenolate mofetil in autoimmune hepatitis: Are we ready for primetime?”

Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD

Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: An analysis of the Indian Consortium on MASLD (ICOM-D) cohort

Estrogen receptor alpha in the female liver: Dr. Jekyll and Mr. Hyde

Integration of new technologies in the multidisciplinary approach to primary liver tumours: The next-generation tumour board

Reply to: correspondance on “A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis”

Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation

Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms

Evidence and choice: The BCLC vision for tailoring clinical decision-making

Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both

Endoscopic diagnosis and treatment for portal hypertension: not yet ready for clinical practice

Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD

Aktive Filter

Suchergebnisse filtern